[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$crdls Graphic](https://lunarcrush.com/gi/w:26/t:$crdls.png) $crdls

$CRDL is up XX% after news this morning. The database lock for the Ph-2 pericarditis trial is complete with topline results expected within two weeks.

### About $crdls
A biotech company.  

### Engagements: XXX [#](/topic/$crdls/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$crdls/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$crdls/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Month**: XXXXXX +430,300%  
**1-Year High**: XXXXXX on 2025-07-22  
**1-Year Low**: X on 2025-06-05  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$crdls/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$crdls/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$crdls/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Month**: X +300%  
**1-Year High**: X on 2025-07-23  
**1-Year Low**: X on 2025-05-08  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$crdls/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$crdls/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$crdls/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $crdls in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Month**: X +100%  
**1-Year High**: X on 2025-04-29  
**1-Year Low**: X on 2025-05-08  

The most influential creators that mention $crdls in the last XX hours

| Creator                              | Rank | Followers | Posts | Engagements |
| -------                              | ---- | --------- | ----- | ----------- |
| [@Gantosj](/creator/twitter/Gantosj) | X    | XXXXXX    | X     | XXX         |

[View More](/list/creators/$crdls/100)
  
  
### Sentiment: XXX% [#](/topic/$crdls/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$crdls/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$crdls/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XXX%  
**1-Year High**: XXX% on 2025-07-23  
**1-Year Low**: XXX% on 2025-07-23  

**Most Supportive Themes**
- **Positive Trial Results:** (70%) Positive news regarding database lock and topline results for the Ph-2 pericarditis trial.
- **Potential for Stock Re-rating:** (30%) Discussion of the potential for rapid stock re-rating based on positive myocarditis data.
  
**Most Critical Themes**
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |
  


**Top topics mentioned**
In the posts about $crdls in the last XX hours

[$crdl](/topic/$crdl), [$pcrx](/topic/$pcrx), [united states](/topic/united-states), [investment](/topic/investment), [$50b](/topic/$50b)

### Top Social Posts [#](/topic/$crdls/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Great move by $CRDL up XX% after the news this morning locking database from its Ph-2 pericarditis trail & topline results within X weeks"  
[@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1947691027759833214) 2025-07-22 16:11:42 UTC 13.3K followers, 1891 engagements


"📣 Biotech Stock News 07/22 @ Open $CRDL XX% Database Lock for Phase X Trial $CNTB XX% Appoints Industry Veteran to Board $STRO X% Research Collab. to Advance Standards $CGEM X% Acceptance of Abstracts for Zipalertinib $BIIB X% Highlighting Progress in Alzheimer's Disease $EHTH X% Achieves HITRUST i1 Certification $AZN X% Plans $50B investment in America $PCRX X% Strategic Collaboration to Expand Promotion $SRPT X% Voluntary Pause of ELEVIDYS Shipments $NAMS X% Presenting Alzheimer's Biomarker Data $DARE X% Webinar on DARE to PLAY Difference $OCUL X% Participation in Scientific Conferences"  
[@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947684863102095511) 2025-07-22 15:47:12 UTC 25.7K followers, 4200 engagements


"$CRDLs current valuation barely reflects the significant progress in its #pericarditis program which has already advanced to Ph-3. If the upcoming Ph-2 #myocarditis data turns out positive the stock could see a rapid re-rating to the upside. The Ph-3 trial for recurrent pericarditis is considered highly de-risked thanks to the robust results from the earlier open-label Ph-2 study which closely mirrors the approach used by an already approved IL-1 blocker"  
[@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1947656179842162968) 2025-07-22 13:53:13 UTC 13.3K followers, 3539 engagements


"So what we should look at from $CRDL's acute #myocarditis Ph-2 data The X primary outcome measures of the trial which were evaluated following XX weeks of double-blind therapy consist of cardiac MRI parameters: global longitudinal strain and extra-cellular volume which assess myocardial function and tissue characteristics associated with fibrosis and inflammation. Both parameters are recognized prognostic markers in patients with acute myocarditis"  
[@Gantosj](/creator/x/Gantosj) on [X](/post/tweet/1947642392980459960) 2025-07-22 12:58:26 UTC 13.3K followers, 7635 engagements